Not applicableUnknownNCT01099852What this trial is testingCohort of Patients Infected by an ArbovirusWho this might be right forFeverDengueChikungunya+1 more University Hospital Center of Martinique 1,377
Large-scale testing (Phase 3)Study completedNCT02058563What this trial is testingImmunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderWho this might be right forRubellaMumpsMeasles GlaxoSmithKline 996
Not applicableStudy completedNCT04909411What this trial is testingConsequences of a Maternal-fetal Chikungunya Virus InfectionWho this might be right forChikungunya Virus Infection Centre Hospitalier Universitaire de la Réunion 42
Not applicableStudy completedNCT02901509What this trial is testingImpact of the Chikungunya Outbreak in Reunion Island on the Quality of Life After 10 YearsWho this might be right forChikungunya FeverQuality of Life Centre Hospitalier Universitaire de la Réunion 386
Not applicableTemporarily pausedNCT05218304What this trial is testingBaromètre Santé Adulte 2021-2022Who this might be right forDiabetesHypercholesterolemiaRenal Failure+7 more Agence Sanitaire et Sociale de Nouvelle Calédonie 5,471
Early research (Phase 1)Study completedNCT03829384What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy AdultsWho this might be right forPrevention of Chikungunya Virus Infection ModernaTX, Inc. 39
Not applicableWithdrawnNCT01738841What this trial is testingSafety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the PhilippinesWho this might be right forMumpsRubellaMeasles+1 more GlaxoSmithKline
Post-approval studies (Phase 4)UnknownNCT01770119What this trial is testingInduction of Immunity Against Measles in Pediatric Liver Transplant RecipientsWho this might be right forMeasles Klara M. Pósfay Barbe 90
Very early researchUnknownNCT03702348What this trial is testingResistance Exercise Program on the Functionality of Individuals With Chikungunya FeverWho this might be right forChikungunya Fever Universidade Federal de Pernambuco 30
Post-approval studies (Phase 4)Study completedNCT03160820What this trial is testingStudy on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) VaccineWho this might be right forMeaslesMumpsRubella+1 more Centers for Disease Control and Prevention, China 873
Large-scale testing (Phase 3)Study completedNCT03148990What this trial is testingStudy to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and RubellaWho this might be right forRubellaMeasles The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 432
Not applicableWithdrawnNCT03204409What this trial is testingZIKAlliance Natural History StudyWho this might be right forZika VirusZika Virus Infection University of Heidelberg Medical Center
Post-approval studies (Phase 4)Looking for participantsNCT06928753What this trial is testingReal-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La RéunionWho this might be right forChikungunya Virus Infection Centre Hospitalier Universitaire de la Réunion 1,800
Early research (Phase 1)Study completedNCT03590392What this trial is testingSafety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)Who this might be right forChikungunya Fever University of Oxford 24
Testing effectiveness (Phase 2)Study completedNCT05630846What this trial is testingA Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of AgeWho this might be right forMeasles; Mumps; Rubella; ChickenpoxMeasles GlaxoSmithKline 801
Not applicableStudy completedNCT04434846What this trial is testingSylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and CambodiaWho this might be right forDengue FeverZikaVector-Borne Diseases+1 more National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT01702428What this trial is testingConsistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of AgeWho this might be right forRubellaMeaslesMumps GlaxoSmithKline 5,016
Large-scale testing (Phase 3)UnknownNCT05894395What this trial is testingImmunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster VaccinationWho this might be right forMumpsMeaslesRubella University of Zurich 200
Large-scale testing (Phase 3)Study completedNCT00985166What this trial is testingProQuad in Healthy 4 to 6 Year Old Children (V221-014)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 801
Large-scale testing (Phase 3)Study completedNCT00432042What this trial is testingImmunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)Who this might be right forVaricellaMeaslesMumps+7 more Merck Sharp & Dohme LLC 955